Addressing the challenges of continuous filtration, washing and drying

Research output: Contribution to conferenceSpeech

Abstract

Continuous synthesis and formulation are becoming established in the pharmaceutical industry, however connecting the two through continuous particle formation and isolation still poses significant challenges. This presentation focuses on continuous filtration, washing and drying. Darcy’s law and subsequent modifications describe the rate of filtration; however, there is no equivalent which addresses the removal of closely related impurities of synthesis by filtration and washing, especially when the product exhibits solubility.
API solubility also poses challenges during drying. Presuming the upstream crystallization has delivered particles of the desired size and they are largely unaffected by filtration and washing then drying process has the potential to break fragile particles and to granulate all particles through the formation of crystal-crystal bridges.
In order to develop a successful continuous system for API filtration, washing and drying all of these problems must be overcome.

Fingerprint

Washing
Drying
Application programming interfaces (API)
Solubility
Crystals
Crystallization
Drug products
Impurities
Pharmaceutical Preparations
Industry

Keywords

  • continuous isolation
  • filtration
  • wahsing
  • drying
  • purification
  • pharmaceutical

Cite this

@conference{453ecd44f8af44fca4f7ce93dd5c1235,
title = "Addressing the challenges of continuous filtration, washing and drying",
abstract = "Continuous synthesis and formulation are becoming established in the pharmaceutical industry, however connecting the two through continuous particle formation and isolation still poses significant challenges. This presentation focuses on continuous filtration, washing and drying. Darcy’s law and subsequent modifications describe the rate of filtration; however, there is no equivalent which addresses the removal of closely related impurities of synthesis by filtration and washing, especially when the product exhibits solubility.API solubility also poses challenges during drying. Presuming the upstream crystallization has delivered particles of the desired size and they are largely unaffected by filtration and washing then drying process has the potential to break fragile particles and to granulate all particles through the formation of crystal-crystal bridges. In order to develop a successful continuous system for API filtration, washing and drying all of these problems must be overcome.",
keywords = "continuous isolation, filtration, wahsing, drying, purification, pharmaceutical",
author = "Price, {Chris John} and Sara Ottoboni",
year = "2017",
month = "2",
day = "23",
language = "English",
note = "Continuous manufacturing 2017 : Adopting Continuous Manufacturing: Defining the Platform for Success, CM2017 ; Conference date: 22-02-2017 Through 23-02-2017",
url = "http://www.cvent.com/events/adoption-of-continuous-manufacturing-in-the-pharmaceutical-industry-workshop/event-summary-990c086634c144269689a6550c454c27.aspx",

}

Price, CJ & Ottoboni, S 2017, 'Addressing the challenges of continuous filtration, washing and drying' Continuous manufacturing 2017, Dublin, Ireland, 22/02/17 - 23/02/17, .

Addressing the challenges of continuous filtration, washing and drying. / Price, Chris John; Ottoboni, Sara.

2017. Continuous manufacturing 2017, Dublin, Ireland.

Research output: Contribution to conferenceSpeech

TY - CONF

T1 - Addressing the challenges of continuous filtration, washing and drying

AU - Price, Chris John

AU - Ottoboni, Sara

PY - 2017/2/23

Y1 - 2017/2/23

N2 - Continuous synthesis and formulation are becoming established in the pharmaceutical industry, however connecting the two through continuous particle formation and isolation still poses significant challenges. This presentation focuses on continuous filtration, washing and drying. Darcy’s law and subsequent modifications describe the rate of filtration; however, there is no equivalent which addresses the removal of closely related impurities of synthesis by filtration and washing, especially when the product exhibits solubility.API solubility also poses challenges during drying. Presuming the upstream crystallization has delivered particles of the desired size and they are largely unaffected by filtration and washing then drying process has the potential to break fragile particles and to granulate all particles through the formation of crystal-crystal bridges. In order to develop a successful continuous system for API filtration, washing and drying all of these problems must be overcome.

AB - Continuous synthesis and formulation are becoming established in the pharmaceutical industry, however connecting the two through continuous particle formation and isolation still poses significant challenges. This presentation focuses on continuous filtration, washing and drying. Darcy’s law and subsequent modifications describe the rate of filtration; however, there is no equivalent which addresses the removal of closely related impurities of synthesis by filtration and washing, especially when the product exhibits solubility.API solubility also poses challenges during drying. Presuming the upstream crystallization has delivered particles of the desired size and they are largely unaffected by filtration and washing then drying process has the potential to break fragile particles and to granulate all particles through the formation of crystal-crystal bridges. In order to develop a successful continuous system for API filtration, washing and drying all of these problems must be overcome.

KW - continuous isolation

KW - filtration

KW - wahsing

KW - drying

KW - purification

KW - pharmaceutical

UR - http://www.cvent.com/events/adoption-of-continuous-manufacturing-in-the-pharmaceutical-industry-workshop/custom-20-990c086634c144269689a6550c454c27.aspx

M3 - Speech

ER -